Asymmetric Alpha, Zero Beta Drift
Hard biochemistry uncovers a structural misprice, not a biotech story in disguise.

Science Anchored Conviction
Sixteen years of privately funded research distilled into market signals rooted in mechanism, never sentiment.

Catalyst Map in Hand
Key clinical and regulatory milestones are plotted in advance, providing a framework for when to pay attention, what may change, and how it could matter.

Live Data Edge

Direct input and first-hand data from participating clinicians and trials turn bedside biology into early, informed updates — well before they appear in public channels.

Founder in the Seat
Gianpaolo works alongside your team to connect the science to your mandate, and support decision making from first signal to final review.